TRCT
COCH icon

Tower Research Capital (TRC)’s Envoy Medical COCH Stock Holding History

Tower Research Capital (TRC)’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,665
Closed -$3.77K – 5271
2026
Q1 		$3.77K Buy
5,665
+2,106
+59% +$1.44K ﹤0.01% 4270
2025
Q4 		$2.35K Sell
3,559
-552
-13% -$437 ﹤0.01% 4548
2025
Q3 		$3.19K Buy
4,111
+872
+27% +$1.18K ﹤0.01% 4535
2025
Q2 		$4.6K Sell
3,239
-328
-9% -$480 ﹤0.01% 4292
2025
Q1 		$4.64K Sell
3,567
-682
-16% -$1K ﹤0.01% 4224
2024
Q4 		$6.08K Buy
4,249
+2,937
+224% +$6.67K ﹤0.01% 4210
2024
Q3 		$4.26K Sell
1,312
-2,729
-68% -$7.42K ﹤0.01% 4620
2024
Q2 		$9.54K Buy
+4,041
New +$15K ﹤0.01% 4234
2024
Q1 		– Sell
-1,714
Closed -$3.1K – 5883
2023
Q4 		$3.1K Buy
+1,714
New +$3.36K ﹤0.01% 5124
2023
Q2 		– Sell
-303
Closed -$3K – 6070
2023
Q1 		$3K Buy
+303
New +$3.04K ﹤0.01% 5177
2022
Q3 		– Sell
-131
Closed -$1K – 6109
2022
Q2 		$1K Buy
131
+130
+13,000% +$1.27K ﹤0.01% 5755
2022
Q1 		$0 Sell
1
-693
-100% -$6.74K ﹤0.01% 6135
2021
Q4 		$7K Buy
+694
New +$6.77K ﹤0.01% 4899

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCA
DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Tower Research Capital (TRC)'s COCH Position: Q2 2026 in Review

Tower Research Capital (TRC) sold out of Envoy Medical (COCH) in Q2 2026, closing a stake of 5,665 shares — an estimated $3.77K sold.

Tower Research Capital (TRC) first reported a position in COCH in Q4 2021 and held it in 13 quarters. The position peaked at $9.54K in Q2 2024. 31 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • Tower Research Capital (TRC) reported no remaining Envoy Medical position as of Q2 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 5,665 Envoy Medical shares in Q2 2026, an estimated $3.77K.
  • Tower Research Capital (TRC) first reported a position in Envoy Medical in Q4 2021 and held it in 13 quarters.
  • Tower Research Capital (TRC)'s Envoy Medical position peaked at $9.54K in Q2 2024.
  • 31 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.